Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Myron M. Cohen"'
Publikováno v:
Pediatrics. 26:42-50
A review of neonatal mortality at the Maternity Division of the Buffalo Children's Hospital from 1948 to 1957 has been presented, with primary emphasis on the occurrence of pulmonary hyaline membrane. During this period there were 26,109 infants born
Autor:
Zhou S; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Long N; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Moeser M; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Hill CS; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Samoff E; North Carolina Department of Health and Human Services, Raleigh, North Carolina, USA., Mobley V; North Carolina Department of Health and Human Services, Raleigh, North Carolina, USA., Frost S; Microsoft Health Futures, Microsoft Corporation, Redmond, Washington, USA.; Department of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, London, United Kingdom., Bayer C; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Kelly E; Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Greifinger A; Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Shone S; North Carolina Department of Health and Human Services, Raleigh, North Carolina, USA., Glover W; North Carolina Department of Health and Human Services, Raleigh, North Carolina, USA., Clark M; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Eron J; Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Cohen M; Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Swanstrom R; Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.; Department of Biochemistry and Biophysics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Dennis AM; Division of Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2023 Dec 20; Vol. 228 (12), pp. 1758-1765.
Autor:
Huang Y; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Global Health, University of Washington, Seattle, Washington, USA., Zhang L; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Eaton A; Duke Human Vaccine Institute, Department of Surgery, Duke University, Durham, North Carolina, USA., Mkhize NN; National Institute for Communicable Diseases, Johannesburg, South Africa., Carpp LN; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Rudnicki E; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., DeCamp A; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Juraska M; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Randhawa A; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., McDermott A; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Ledgerwood J; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Andrew P; Family Health International, Durham, North Carolina, USA., Karuna S; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Edupuganti S; Division of Infectious Diseases, Department of Medicine, Emory University, Decatur, Georgia, USA., Mgodi N; Clinical Trials Research Centre, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe., Cohen M; Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, North Carolina, USA.; Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, USA., Corey L; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Departments of Medicine and Laboratory Medicine, University of Washington, Seattle, Washington, USA., Mascola J; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Gilbert PB; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Biostatistics, University of Washington, Seattle, Washington, USA., Morris L; National Institute for Communicable Diseases, Johannesburg, South Africa., Montefiori DC; Duke Human Vaccine Institute, Department of Surgery, Duke University, Durham, North Carolina, USA.
Publikováno v:
Human vaccines & immunotherapeutics [Hum Vaccin Immunother] 2022 Dec 31; Vol. 18 (1), pp. 1908030. Date of Electronic Publication: 2021 Jul 02.
Autor:
Takuva S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA.; Perinatal HIV Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.; School of Health Systems and Public Health, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa., Karuna ST; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Juraska M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Rudnicki E; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Edupuganti S; Division of Infectious Disease, Department of Medicine, Emory University, Atlanta, GA., Anderson M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA., De La Grecca R; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Gaudinski MR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Sehurutshi A; Botswana Harvard AIDS Institute, Gaborone, Botswana, South Africa., Orrell C; Department of Medicine, Desmond Tutu HIV Center, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa., Naidoo L; South African Medical Research Council, Durban, South Africa., Valencia J; Asociacion Civil Impacta Salud y Educacion, Lima, Peru., Villela LM; Instituto Nacional de Infectologia Evandro Chagas, Fundação Oswaldo Cruz (INI-Fiocruz), Rio de Janeiro, Brazil., Walsh SR; Division of Infectious Diseases, Brigham and Women's Hospital, Boston, MA., Andrew P; Family Health International, Durham, NC., Karg C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Randhawa A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Hural J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Gomez Lorenzo MM; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Burns DN; Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Ledgerwood J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD., Cohen M; Department of Medicine, University of North Carolina, Chapel Hill, NC., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA., Mngadi K; Aurum Institute, Johannesburg, South Africa; and., Mgodi NM; University of Zimbabwe Clinical Trials Research Center, Harare, Zimbabwe.
Publikováno v:
Journal of acquired immune deficiency syndromes (1999) [J Acquir Immune Defic Syndr] 2022 Apr 01; Vol. 89 (4), pp. 405-413.
Autor:
Chagomerana MB; 156288UNC Project-Malawi, Lilongwe, Malawi.; Department of Medicine, 6797University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Hosseinipour MC; 156288UNC Project-Malawi, Lilongwe, Malawi.; Department of Medicine, 6797University of North Carolina at Chapel Hill, Chapel Hill, NC, USA., Pilotto JH; 37903Hospital Geral de Nova Iguacu and Laboratorio de AIDS e Imunologia Molecular-IOC/Fiocruz, Rio de Janeiro, Brazil., Badal-Faesen S; Clinical HIV Research Unit, Faculty of Health Sciences, 37707University of the Witwatersrand, Johannesburg, South Africa., Nyirenda M; Johns Hopkins Project, 37610University of Malawi College of Medicine, Blantyre, Malawi., Shava E; 292006Botswana Harvard Aids Institute Partnership, Gaborone, Botswana., Godbole SV; CMR-National AIDS Research Institute, Pune, India., Akelo V; Kenya Medical Research Institute (KEMRI), Nairobi, Kenya., Chariyalertsak S; Research Institute for Health Sciences, 26682Chiang Mai University, Chiang Mai, Thailand.; Faculty of Public Health, 26682Chiang Mai University, Suthep, Thailand., Panchia R; Perinatal HIV Research Unit, 196579University of the Witwatersrand, Soweto HPTN CRS, Soweto, South Africa., Cohen M; Department of Medicine, 6797University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Publikováno v:
International journal of STD & AIDS [Int J STD AIDS] 2021 Nov; Vol. 32 (13), pp. 1204-1211. Date of Electronic Publication: 2021 Jul 07.
Autor:
Zhou S; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Sizemore S; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Moeser M; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Zimmerman S; North Carolina Department of Health and Human Services, Raleigh, North Carolina, USA., Samoff E; North Carolina Department of Health and Human Services, Raleigh, North Carolina, USA., Mobley V; North Carolina Department of Health and Human Services, Raleigh, North Carolina, USA., Frost S; University of Cambridge, Cambridge, United Kingdom., Cressman A; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Clark M; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Skelly T; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Kelkar H; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Veluvolu U; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Jones C; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Eron J; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Cohen M; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Nelson JAE; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Swanstrom R; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA., Dennis AM; University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA.
Publikováno v:
The Journal of infectious diseases [J Infect Dis] 2021 Mar 03; Vol. 223 (5), pp. 876-884.
Autor:
Huang Y; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America; Department of Global Health, University of Washington, Seattle, WA, United States of America. Electronic address: yunda@scharp.org., Naidoo L; HIV Prevention Research Unit, South African Medical Research Council, Durban, South Africa., Zhang L; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Carpp LN; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Rudnicki E; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Randhawa A; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Gonzales P; Asociacion Civil Impacta Salud y Educacion, Lima, Perú., McDermott A; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America., Ledgerwood J; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America., Lorenzo MMG; Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States of America., Burns D; Division of AIDS, National Institute of Allergy and Infectious Diseases, Bethesda, MD, United States of America., DeCamp A; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Juraska M; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Mascola J; Vaccine Research Center (VRC), National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, United States of America., Edupuganti S; Division of Infectious Diseases, Department of Medicine, Emory University, Decatur, United States of America., Mgodi N; Clinical Trials Research Centre, University of Zimbabwe College of Health Sciences, Harare, Zimbabwe., Cohen M; Department of Medicine, Division of Infectious Diseases, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill, NC 27599, United States of America; Institute for Global Health and Infectious Diseases, University of North Carolina, Chapel Hill, NC, United States of America., Corey L; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America; Departments of Medicine and Laboratory Medicine, University of Washington, Seattle, WA, United States of America., Andrew P; Family Health International, Durham, NC, United States of America., Karuna S; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America., Gilbert PB; Vaccine and Infectious Diseases Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America; Public Health Sciences Division, Fred Hutchinson Cancer Research Center, Seattle, WA, United States of America; Department of Biostatistics, University of Washington, Seattle, WA, United States of America., Mngadi K; Centre for the AIDS Programme of Research in South Africa, Durban, South Africa., Lazarus E; Perinatal HIV Research Unit (PHRU), Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, Gauteng, South Africa.
Publikováno v:
EBioMedicine [EBioMedicine] 2021 Feb; Vol. 64, pp. 103203. Date of Electronic Publication: 2021 Jan 23.
Autor:
Elliott T; Imperial College London, London, United Kingdom.; Imperial College Healthcare NHS Trust, London, United Kingdom., Sanders EJ; Kenya Medical Research Institute-Wellcome Trust Research Programme, Kilifi, Kenya.; Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom., Doherty M; Department of HIV and Global Hepatitis Programme, WHO, Geneva, Switzerland., Ndung'u T; Africa Health Research Institute, Durban, South Africa.; HIV Pathogenesis Programme, Doris Duke Medical Research Institute, University of KwaZulu-Natal, Durban, South Africa.; The Ragon Institute of Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard University, Cambridge, MA, USA.; Max Planck Institute for Infection Biology, Berlin, Germany., Cohen M; Department of Internal Medicine, Division of Infectious Diseases, UNC School of Medicine, University of North Carolina At Chapel Hill, Chapel Hill, NC, USA., Patel P; Division of Global HIV and TB, Centers for Disease Control and Prevention, Atlanta, GA, USA., Cairns G; NAM Aidsmap, London, United Kingdom.; PrEP in Europe Initiative, London, United Kingdom., Rutstein SE; Department of Internal Medicine, Division of Infectious Diseases, UNC School of Medicine, University of North Carolina At Chapel Hill, Chapel Hill, NC, USA., Ananworanich J; U.S. Military HIV Research Program, Walter Reed Army Institute of Research, Silver Spring, MD, USA.; Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, USA., Brown C; National Infection Service, Public Health England, London, United Kingdom.; Department of Infection, Royal Free London NHS Foundation Trust, London, United Kingdom., Fidler S; Imperial College London, London, United Kingdom.; Imperial College NIHR BRC, London, United Kingdom.
Publikováno v:
Journal of the International AIDS Society [J Int AIDS Soc] 2019 Dec; Vol. 22 (12), pp. e25419.
Autor:
Alam SM; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.; Department of Pathology, Duke University School of Medicine, Durham, NC 27710, USA., Aussedat B; Department of Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Vohra Y; Department of Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Meyerhoff RR; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA., Cale EM; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Walkowicz WE; Department of Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Radakovich NA; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Anasti K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Armand L; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Parks R; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Sutherland L; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Scearce R; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Joyce MG; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Pancera M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Druz A; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Georgiev IS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Von Holle T; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Eaton A; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Fox C; Infectious Disease Research Institute, Seattle, WA 98102, USA., Reed SG; Infectious Disease Research Institute, Seattle, WA 98102, USA., Louder M; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Bailer RT; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Morris L; National Institute for Communicable Diseases, Johannesburg 2131, South Africa.; Center for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban 4013, South Africa., Abdool-Karim SS; National Institute for Communicable Diseases, Johannesburg 2131, South Africa.; Center for the AIDS Programme of Research in South Africa, University of KwaZulu-Natal, Durban 4013, South Africa., Cohen M; Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Liao HX; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA., Montefiori DC; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA., Park PK; Department of Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Fernández-Tejada A; Department of Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Wiehe K; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA., Santra S; Beth Israel Deaconess Medical Center, Boston, MA 02215, USA., Kepler TB; Department of Microbiology, Boston University School of Medicine, Boston, MA 02118, USA., Saunders KO; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Department of Surgery, Duke University School of Medicine, Durham, NC 27710, USA., Sodroski J; Dana-Farber Cancer Institute, Harvard Medical School, 450 Brookline Avenue, Boston, MA 02215, USA., Kwong PD; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892, USA., Bonsignori M; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA., Moody MA; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA.; Department of Pediatrics, Duke University School of Medicine, Durham, NC 27710, USA., Danishefsky S; Department of Chemical Biology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Haynes BF; Duke Human Vaccine Institute, Duke University School of Medicine, Durham, NC 27710, USA.; Department of Medicine, Duke University School of Medicine, Durham, NC 27710, USA.; Department of Immunology, Duke University School of Medicine, Durham, NC 27710, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2017 Mar 15; Vol. 9 (381).
Autor:
Gilbert PB; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.; Department of Biostatistics, University of Washington, Seattle, Washington, USA., Juraska M; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., deCamp AC; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Karuna S; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Edupuganti S; Department of Medicine, Emory University, Atlanta, Georgia, USA., Mgodi N; University of Zimbabwe - University of California San Francisco Research Program, Harare, Zimbabwe., Donnell DJ; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Bentley C; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Sista N; FHI 360 Durham, North Carolina, USA., Andrew P; FHI 360 Durham, North Carolina, USA., Isaacs A; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Huang Y; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Zhang L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Capparelli E; Department of Pediatrics, University of California, San Diego, California, USA., Kochar N; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Wang J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Eshleman SH; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA., Mayer KH; The Fenway Institute, Boston, Massachusetts, USA.; Department of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.; Department of Medicine, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Magaret CA; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Hural J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Kublin JG; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Gray G; South African Medical Research Council, Cape Town, South Africa; Perinatal HIV Research Unit, University of the Witwatersrand, Braamfontein, Johannesburg, South Africa.; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Montefiori DC; Duke University Medical Center, Durham, North Carolina, USA., Gomez MM; Vaccine Research Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Burns DN; Prevention Sciences Program, Division of AIDS, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., McElrath J; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA., Ledgerwood J; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Graham BS; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Mascola JR; Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA., Cohen M; Department of Medicine, University of North Carolina, Chapel Hill, North Carolina, USA., Corey L; Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA.
Publikováno v:
Statistical communications in infectious diseases [Stat Commun Infect Dis] 2017 Jan; Vol. 9 (1). Date of Electronic Publication: 2017 Jun 06.